Literature DB >> 8424820

Nature and role of xenobiotic metabolizing esterases in rat liver, lung, skin and blood.

N W McCracken1, P G Blain, F M Williams.   

Abstract

In the present study, the distribution and nature of esterases in the rat which hydrolysed fluazifop-butyl, carbaryl, paraoxon and phenylacetate were investigated. Vmax and Km values for the hydrolysis reactions were determined. Fluazifop-butyl was hydrolysed to fluazifop by rat liver (Vmax mumol/min/g microsomes 6.2 +/- 0.4; cytosol 6.84 +/- 0.85), lung (Vmax microsomes 0.38 +/- 0.1; cytosol 1.5 +/- 0.32) and skin (Vmax microsomes 0.02 +/- 0.0015; cytosol 0.4 +/- 0.06) and by plasma (Vmax mumol/min/mL 5.8 +/- 0.48) and red blood cells (Vmax 0.03 +/- 0.015). Significant inhibition by paraoxon and bismitrophenol phosphate indicated the involvement of carboxylesterases. Carbaryl was hydrolysed by liver, lung and skin at a lower rate by microsomal fractions (Vmax nmol/min/g 2.1 +/- 0.25, 1.6 +/- 0.25, 0.2 +/- 0.035, respectively) compared to cytosolic fractions (Vmax 6.7 +/- 0.75, 1.4 +/- 0.36, 0.5 +/- 0.12) and plasma (Vmax nmol/min/mL 3.0 +/- 0.25). Hydrolysis involved carboxylesterases. Paraoxon was hydrolysed by paraoxonases/arylesterases only in the plasma (Vmax nmol/min/mL 246 +/- 12) and microsomal fractions from liver (Vmax 330 nmol/min/g +/- 25) and lung (Vmax 2 +/- 0.25). Phenylacetate was hydrolysed by both microsomal and cytosolic fractions from all tissues studied. Hydrolysis involved arylesterases in the microsomes and carboxylesterases in the cytosol. Extrahepatic hydrolysis may be important following some routes of exposure to xenobiotic esters.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8424820     DOI: 10.1016/0006-2952(93)90373-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

Review 1.  Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.

Authors:  F Oesch; E Fabian; Robert Landsiedel
Journal:  Arch Toxicol       Date:  2018-06-18       Impact factor: 5.153

Review 2.  Xenobiotic-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.

Authors:  F Oesch; E Fabian; K Guth; R Landsiedel
Journal:  Arch Toxicol       Date:  2014-11-05       Impact factor: 5.153

3.  Deacetylation of diltiazem by several rabbit tissues.

Authors:  L J Fraile; J J Aramayona; M A Bregante; M A García; A R Abadía
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

4.  Characterization of pulmonary alveolar esterases of the primate Cercopithecus pygerythrus.

Authors:  H M Leng; J A Syce
Journal:  Pharm Res       Date:  1997-02       Impact factor: 4.200

5.  Synthesis of piperlogs and analysis of their effects on cells.

Authors:  Zarko V Boskovic; Mahmud M Hussain; Drew J Adams; Mingji Dai; Stuart L Schreiber
Journal:  Tetrahedron       Date:  2013-09-09       Impact factor: 2.457

6.  Esterase Activity and Intracellular Localization in Reconstructed Human Epidermal Cultured Skin Models.

Authors:  Yoshihiro Tokudome; Mishina Katayanagi; Fumie Hashimoto
Journal:  Ann Dermatol       Date:  2015-05-29       Impact factor: 1.444

7.  Sofosbuvir as Repurposed Antiviral Drug Against COVID-19: Why Were We Convinced to Evaluate the Drug in a Registered/Approved Clinical Trial?

Authors:  Babak Sayad; Mahsa Sobhani; Reza Khodarahmi
Journal:  Arch Med Res       Date:  2020-04-29       Impact factor: 2.235

8.  Tioconazole and Chloroquine Act Synergistically to Combat Doxorubicin-Induced Toxicity via Inactivation of PI3K/AKT/mTOR Signaling Mediated ROS-Dependent Apoptosis and Autophagic Flux Inhibition in MCF-7 Breast Cancer Cells.

Authors:  Afnan H El-Gowily; Samah A Loutfy; Ehab M M Ali; Tarek M Mohamed; Mohammed A Mansour
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.